US company bails on Mayne Pharma takeover

Mayne Pharma says its US suitor Cosette wants to walk away from a $672m takeover of the Australian company Listed Mayne Pharma has told the market Cosette issued a notice to terminate the arrangement due to what it saw as a “material adverse change” since it made its bid. Mayne Pharma challenged that view, but